These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21547498)

  • 1. Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia.
    Visser ME; Lammers NM; Nederveen AJ; van der Graaf M; Heerschap A; Ackermans MT; Sauerwein HP; Stroes ES; Serlie MJ
    Diabetologia; 2011 Aug; 54(8):2113-21. PubMed ID: 21547498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis.
    Schonfeld G; Patterson BW; Yablonskiy DA; Tanoli TS; Averna M; Elias N; Yue P; Ackerman J
    J Lipid Res; 2003 Mar; 44(3):470-8. PubMed ID: 12562873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia.
    Amaro A; Fabbrini E; Kars M; Yue P; Schechtman K; Schonfeld G; Klein S
    Gastroenterology; 2010 Jul; 139(1):149-53. PubMed ID: 20303351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty liver and insulin resistance in children with hypobetalipoproteinemia: the importance of aetiology.
    Della Corte C; Fintini D; Giordano U; Cappa M; Brufani C; Majo F; Mennini C; Nobili V
    Clin Endocrinol (Oxf); 2013 Jul; 79(1):49-54. PubMed ID: 22789032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes.
    Perseghin G; Lattuada G; De Cobelli F; Esposito A; Costantino F; Canu T; Scifo P; De Taddeo F; Maffi P; Secchi A; Del Maschio A; Luzi L
    Diabetologia; 2005 Dec; 48(12):2615-21. PubMed ID: 16261312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease.
    Croci I; Byrne NM; Choquette S; Hills AP; Chachay VS; Clouston AD; O'Moore-Sullivan TM; Macdonald GA; Prins JB; Hickman IJ
    Gut; 2013 Nov; 62(11):1625-33. PubMed ID: 23077135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms.
    Bugianesi E; Gastaldelli A; Vanni E; Gambino R; Cassader M; Baldi S; Ponti V; Pagano G; Ferrannini E; Rizzetto M
    Diabetologia; 2005 Apr; 48(4):634-42. PubMed ID: 15747110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity.
    Tanoli T; Yue P; Yablonskiy D; Schonfeld G
    J Lipid Res; 2004 May; 45(5):941-7. PubMed ID: 14967820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia.
    Di Filippo M; Moulin P; Roy P; Samson-Bouma ME; Collardeau-Frachon S; Chebel-Dumont S; Peretti N; Dumortier J; Zoulim F; Fontanges T; Parini R; Rigoldi M; Furlan F; Mancini G; Bonnefont-Rousselot D; Bruckert E; Schmitz J; Scoazec JY; Charrière S; Villar-Fimbel S; Gottrand F; Dubern B; Doummar D; Joly F; Liard-Meillon ME; Lachaux A; Sassolas A
    J Hepatol; 2014 Oct; 61(4):891-902. PubMed ID: 24842304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents.
    D'Adamo E; Cali AM; Weiss R; Santoro N; Pierpont B; Northrup V; Caprio S
    Diabetes Care; 2010 Aug; 33(8):1817-22. PubMed ID: 20668154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic and peripheral insulin sensitivity do not improve 2 weeks after bariatric surgery.
    de Weijer BA; Aarts E; Janssen IM; Berends FJ; van de Laar A; Kaasjager K; Ackermans MT; Fliers E; Serlie MJ
    Obesity (Silver Spring); 2013 Jun; 21(6):1143-7. PubMed ID: 23913729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic insulin resistance in antipsychotic naive schizophrenic patients: stable isotope studies of glucose metabolism.
    van Nimwegen LJ; Storosum JG; Blumer RM; Allick G; Venema HW; de Haan L; Becker H; van Amelsvoort T; Ackermans MT; Fliers E; Serlie MJ; Sauerwein HP
    J Clin Endocrinol Metab; 2008 Feb; 93(2):572-7. PubMed ID: 18029467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty liver and insulin resistance: not always linked.
    Schonfeld G; Yue P; Lin X; Chen Z
    Trans Am Clin Climatol Assoc; 2008; 119():217-23; discussion 223-4. PubMed ID: 18596860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic steatosis and insulin resistance: does etiology make a difference?
    Lonardo A; Lombardini S; Scaglioni F; Carulli L; Ricchi M; Ganazzi D; Adinolfi LE; Ruggiero G; Carulli N; Loria P
    J Hepatol; 2006 Jan; 44(1):190-6. PubMed ID: 16168516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic consequences of adipose triglyceride lipase deficiency in humans: an in vivo study in patients with neutral lipid storage disease with myopathy.
    Natali A; Gastaldelli A; Camastra S; Baldi S; Quagliarini F; Minicocci I; Bruno C; Pennisi E; Arca M
    J Clin Endocrinol Metab; 2013 Sep; 98(9):E1540-8. PubMed ID: 23824421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramyocellular lipid levels are associated with peripheral, but not hepatic, insulin sensitivity in normal healthy subjects.
    Salgin B; Sleigh AJ; Williams RM; Jackson SJ; Bluck LJ; Murgatroyd PR; Humphreys SM; Harding S; Carpenter TA; Dunger DB
    Clin Sci (Lond); 2009 Jul; 117(3):111-8. PubMed ID: 19093914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid metabolism and insulin resistance in cirrhosis.
    Kaye GL; Kruszynska YT; Harry DS; Heslop K; Johnston DG; McIntyre N
    J Hepatol; 1994 Jun; 20(6):782-91. PubMed ID: 7930479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C.
    Vanni E; Abate ML; Gentilcore E; Hickman I; Gambino R; Cassader M; Smedile A; Ferrannini E; Rizzetto M; Marchesini G; Gastaldelli A; Bugianesi E
    Hepatology; 2009 Sep; 50(3):697-706. PubMed ID: 19582803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver.
    Monetti M; Levin MC; Watt MJ; Sajan MP; Marmor S; Hubbard BK; Stevens RD; Bain JR; Newgard CB; Farese RV; Hevener AL; Farese RV
    Cell Metab; 2007 Jul; 6(1):69-78. PubMed ID: 17618857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver fat content and hepatic insulin sensitivity in overweight patients with type 1 diabetes.
    Llauradó G; Sevastianova K; Sädevirta S; Hakkarainen A; Lundbom N; Orho-Melander M; Groop PH; Forsblom C; Yki-Järvinen H
    J Clin Endocrinol Metab; 2015 Feb; 100(2):607-16. PubMed ID: 25405502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.